November 14, 2024
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
The purpose of this Notice is to inform potential applicants that effective November 15, 2024, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) will participate in RFA-NS-25-022, "BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)", issued by the National Institutes of Health.
The following text has been added to reflect NIBIBs participation in the NOFO:
Part 1. Overview Information
Components of Participating Organizations
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.286
All other aspects of the NOFO remain the same.
Please direct all inquiries to:
Michael Wolfson
NIBIB/OPESP
Telephone: 301-451-4778
Email: [email protected]